Empowering Pharmaceutical Manufacturing Excellence

The Pharma University is a knowledge-driven community dedicated to advancing expertise in pharmaceutical manufacturing, validation, automation, engineering, and regulatory compliance. Our platform offers foundational courses, industry-focused blogs, and expert insights designed to equip professionals with the practical skills and regulatory knowledge needed to excel in a rapidly evolving industry.

Stay Updated With the Latest News

Your source for insights on emerging trends and regulatory updates shaping pharmaceutical manufacturing.

FDA Approves Mirum Pharmaceuticals' Treatment for Rare Genetic Disorder

The U.S. Food and Drug Administration has approved Mirum Pharmaceuticals' new drug designed to treat a rare genetic disorder that impairs the body's ability to process cholesterol. This approval provides a new therapeutic option for patients suffering from this condition, marking a significant advancement in addressing rare lipid storage diseases.

Sun Pharma to Acquire Checkpoint Therapeutics for $355 Million

India's Sun Pharmaceutical Industries has announced its acquisition of U.S.-based Checkpoint Therapeutics for $355 million. This strategic move aims to expand Sun Pharma's oncology and immunotherapy portfolio. Checkpoint Therapeutics has developed UNLOXCYT, a treatment for advanced skin cancer approved by the FDA, which will now be part of Sun Pharma's offerings.